
Amikacin is a semisynthetic aminoglycoside antibiotic derived from kanamycin and is used similarly to gentamicin in the treatment of severe Gram-negative and other infections. It is given as the sulfate, and is generally reserved for the treatment of severe infections caused by susceptible bacteria that are resistant to gentamicin and tobramycin.